<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Que Z</submitter><funding>HHS | National Institutes of Health</funding><funding>Fulbright-Colciencias scholarship</funding><funding>Purdue Big Idea Challenge 2.0 on Autism</funding><funding>FamilieSCN2A foundation</funding><funding>NCATS NIH HHS</funding><funding>NIEHS NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>Indiana Clinical and Translational Sciences Institute</funding><funding>NINDS NIH HHS</funding><funding>NCI NIH HHS</funding><funding>National Science Foundation (NSF) Graduate Research Fellowship Program</funding><funding>Ralph W. and Grace M. Showalter Research Trust Fund</funding><pagination>10194-10208</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8660047</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>41(49)</volume><pubmed_abstract>With the wide adoption of genomic sequencing in children having seizures, an increasing number of &lt;i>SCN2A&lt;/i> genetic variants have been revealed as genetic causes of epilepsy. Voltage-gated sodium channel Nav1.2, encoded by gene &lt;i>SCN2A&lt;/i>, is predominantly expressed in the pyramidal excitatory neurons and supports action potential (AP) firing. One recurrent &lt;i>SCN2A&lt;/i> genetic variant is L1342P, which was identified in multiple patients with epileptic encephalopathy and intractable seizures. However, the mechanism underlying L1342P-mediated seizures and the pharmacogenetics of this variant in human neurons remain unknown. To understand the core phenotypes of the L1342P variant in human neurons, we took advantage of a reference human-induced pluripotent stem cell (hiPSC) line from a m</pubmed_abstract><journal>The Journal of neuroscience : the official journal of the Society for Neuroscience</journal><pubmed_title>Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human iPSCs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant.</pubmed_title><pmcid>PMC8660047</pmcid><funding_grant_id>R01 NS117585</funding_grant_id><funding_grant_id>R01 AI150847</funding_grant_id><funding_grant_id>R03 NS108229</funding_grant_id><funding_grant_id>Action Potential Grant</funding_grant_id><funding_grant_id>DGE-1842166</funding_grant_id><funding_grant_id>R01 CA212403</funding_grant_id><funding_grant_id>R01 ES031401</funding_grant_id><funding_grant_id>R01 NS123154</funding_grant_id><funding_grant_id>UL1 TR002529</funding_grant_id><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Skarnes WC</pubmed_authors><pubmed_authors>Shafer JM</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Bowman AB</pubmed_authors><pubmed_authors>Trader DJ</pubmed_authors><pubmed_authors>Wettschurack K</pubmed_authors><pubmed_authors>Schaber JA</pubmed_authors><pubmed_authors>Tukker AM</pubmed_authors><pubmed_authors>Xiao T</pubmed_authors><pubmed_authors>Eaton M</pubmed_authors><pubmed_authors>Yuan C</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Huang Z</pubmed_authors><pubmed_authors>Que Z</pubmed_authors><pubmed_authors>Olivero-Acosta MI</pubmed_authors><pubmed_authors>Xie J</pubmed_authors><pubmed_authors>Hu CD</pubmed_authors><pubmed_authors>Yunis L</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Rochet JC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human iPSCs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant.</name><description>With the wide adoption of genomic sequencing in children having seizures, an increasing number of &lt;i>SCN2A&lt;/i> genetic variants have been revealed as genetic causes of epilepsy. Voltage-gated sodium channel Nav1.2, encoded by gene &lt;i>SCN2A&lt;/i>, is predominantly expressed in the pyramidal excitatory neurons and supports action potential (AP) firing. One recurrent &lt;i>SCN2A&lt;/i> genetic variant is L1342P, which was identified in multiple patients with epileptic encephalopathy and intractable seizures. However, the mechanism underlying L1342P-mediated seizures and the pharmacogenetics of this variant in human neurons remain unknown. To understand the core phenotypes of the L1342P variant in human neurons, we took advantage of a reference human-induced pluripotent stem cell (hiPSC) line from a m</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-22T05:52:20.795Z</modification><creation>2025-04-05T21:27:47.101Z</creation></dates><accession>S-EPMC8660047</accession><cross_references><pubmed>34716231</pubmed><doi>10.1523/JNEUROSCI.0564-21.2021</doi><doi>10.1523/jneurosci.0564-21.2021</doi></cross_references></HashMap>